S-Adenosylmethionine Inhibits Expression of Vascular Endothelial Growth Factor-C Protein and Cellular Proliferation in Gastric Cancer
Abstract
To explore inhibitory effects of S-adenosylmethionine on vascular endothelial growth factor-C (VEGF-C) protein and cellular proliferation in gastric cancer by regulating methylation status of VEGF-C promoter. Methods MTT analyses and nude mice model were employed to examine the effects of S-adenosylmethionine on inhibiting gastric cancer growth In vitro and in vitro The protein expression of VEGF-C in gastric cancer cells was assessed by Western blot. The methylation status of VEGF-C promoter was assessed by bisulfite genomic DNA sequencing analysis. Results VEGF-C promoter was hypomethylated in MGC803 and SGC7901. The treatment of S-adenosylmethionine resulted in a heavy hypermethylation of VEGF-C promoter, which consequently down regulated protein level of VEGF-C. S-adenosylmethionine effectively inhibited the growth of gastric cancer cells In vitro and in vitro (P<0.05). Conclusion S-adenosylmethionine can effectively reverse DNA hypomethylation on VEGF-C promoter which down-regulates VEGF-C protein expression and inhibit gastric cancer growth.
Keywords: S-adenosylmethionine VEGF-C, Methylation, Gastric cancer
Full Text:
PDFReferences
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin,2005;55(2) :74-108.
Rashid A, Issa JPJ. CpG island methylation in gastroenterologic neoplasia; a maturing field. Gastroenterology,2004 ; 127(5) ; 1578-1588.
Baylin SB, Ohm JE. Epigenetic gene silencing in cancer a mechanism for early oncogenic pathway addiction? Nat Rev Cancer,2006;6(2): 107-116.
Bhutani N, Brady JJ, Damian M, et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature,2009;463(7284) : 1042-1047.
Laird PW. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Cancer,2010; 11 (3); 191-203. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol,2005;35(3); 227-234.
Lewis JD, Meehan RR, Henzel WJ, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 1992; 69( 6) : 905- 914.
Ramani K, Yang H, Kuhlenkamp J, et al. Changes in the expression of methionine adenosyltransferase genes and S- adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology, 2010; 51(3) ; 986-995.
Luka Z, Mudd SH, Wagner C. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J Biol Chem, 2009;284(34):22507-22511.
Luo J, Li YN, Wang F. et al. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. Int J Biol Sci»2010;6(7) :784-784.
Escoubet-Lozach L, Lin IL, Jensen-Pergakes K, et al. Pomalidomide and lenalidomide induce p21WAF-l expression in both lymphoma and multiple myeloma through a LSD1- mediated epigenetic mechanism. Cancer Res, 2009; 69 ( 18 ) ; 7317-7356.
Majid S. Dar AA, Ahmad AE. et al. BTG3 tumor suppressor gene promoter demethylation. histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis,2009; 30(4):662-670.
McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res,2009; 15( 12) :3927-3937.
Ehrlich M. DNA methylation in cancer; too much, but also too little. Oncogene,2002; 21 (21); 5400-5413.
Choi JY, James SR, Link PA, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis,2009 ; 30( 11): 1889-1897.
Richards KL, Zhang B, Baggerly KA, et al. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One, 2009; 4 (3); e4941. doi: 10. 1371/ journal, pone. 0004941.
Honda T, Tamura G, Waki T, elal. Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer, 2004; 90(4): 838-843.
Yanagawa N, Tamura G, Honda T, et al. Demethylation of the synuclein у gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res, 2004; 10 ( 7); 2447- 2451.
Ouo Y, Pakneshan P. Gladu J, et al. Regulation of DNA methylation in human breast cancer. Effect on the urokinase- type plasminogen activator gene production and tumor invasion. J Biol Chem,2002;277(44):41571-41579.
Matsumura S, Oue N, Mitani Y. et al. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer,2007 ; 120(8); 1689-1695.
Hirakawa S, Brown LF. Kodama S, et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood,2007; 109(3); 1010-1017.
Da MX, Wu XT, Wang J, et al. Expression of cyclooxygenase- 2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res,2008;39( 1) :92-99.
Liu L. Ma XL, Xiao ZL, et al. Prognostic 4'alue of vascular endothelial growth factor expression in resected gastric cancer. Asian Рас J Cancer Prev,2012; 13( 13);3089-3907.
He W, Tang B, Yang D, et al. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor С indicates a poorer prognosis in gastric cancer patients. World J Surg Oncol, 2013 Jul 18; 11; 161. doi; 10. 1186/1477- 7819-11-161.
Guo B, Zhang Y, Luo G, et al. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Anat Rec, 2009;292(5):633-639.
Zhu P. Zhang J. Chen Q. et al. Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901. Am J Sur. 2012; 204( 1); 78- 83.
Yao JB, Da MX, Guo TK, et al. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in-vivo in mice. Tumor BioU2013;34(3): 1493-1501.
Refbacks
- There are currently no refbacks.
